CINECA IRIS Institutional Research Information System

ROMAGNOLO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.368
EU - Europa 1.829
AS - Asia 835
SA - Sud America 58
OC - Oceania 30
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.306
IT - Italia 504
CN - Cina 464
IE - Irlanda 280
SE - Svezia 257
FR - Francia 139
DE - Germania 119
AT - Austria 111
JP - Giappone 110
GB - Regno Unito 84
IN - India 55
CA - Canada 52
VN - Vietnam 49
ES - Italia 46
FI - Finlandia 45
KR - Corea 42
BR - Brasile 39
PL - Polonia 36
UA - Ucraina 35
BE - Belgio 34
TR - Turchia 28
NL - Olanda 27
AU - Australia 26
HK - Hong Kong 21
CH - Svizzera 17
GR - Grecia 16
RO - Romania 16
SG - Singapore 16
PT - Portogallo 15
TW - Taiwan 13
CZ - Repubblica Ceca 10
MX - Messico 10
AR - Argentina 9
RU - Federazione Russa 9
IR - Iran 6
SN - Senegal 6
UZ - Uzbekistan 6
BG - Bulgaria 5
ID - Indonesia 5
PH - Filippine 5
SI - Slovenia 5
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
MY - Malesia 4
NZ - Nuova Zelanda 4
CY - Cipro 3
EG - Egitto 3
HR - Croazia 3
IL - Israele 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CM - Camerun 2
HU - Ungheria 2
MA - Marocco 2
MT - Malta 2
RS - Serbia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
IS - Islanda 1
KW - Kuwait 1
MD - Moldavia 1
PE - Perù 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 6.140
Salva come PNG Salva come JPEG
Città #
Chandler 629
Dublin 278
Beijing 224
Ann Arbor 191
Torino 188
Ashburn 183
Fairfield 172
Houston 116
Nyköping 116
Vienna 104
Wilmington 94
Redwood City 91
Woodbridge 88
Medford 87
Princeton 79
Villeurbanne 74
Seattle 59
Dearborn 58
Cambridge 48
Boston 40
Jacksonville 38
Dong Ket 37
Boardman 30
Hangzhou 30
Pisa 28
Brussels 27
Fremont 26
New York 26
Turin 24
Milan 22
Seoul 21
Warsaw 20
Nanjing 18
Chengdu 17
Madrid 17
Shanghai 15
Tokyo 15
Norwalk 14
Ottawa 14
Hebei 13
Washington 13
Guangzhou 12
Los Angeles 12
Xian 12
Central District 11
Singapore 11
São Paulo 11
Dallas 9
Hefei 9
Helsinki 9
London 9
Taipei 9
Toronto 9
Wuhan 9
Barcelona 8
Fort Worth 8
Riverton 8
San Diego 8
Falls Church 7
Jinan 7
Mumbai 7
Rome 7
Silver Spring 7
Buenos Aires 6
Sydney 6
Verona 6
Bethesda 5
Bologna 5
Bricherasio 5
Chongqing 5
Duncan 5
Hamburg 5
Hiroshima 5
Istanbul 5
Melbourne 5
Rochester 5
Zhengzhou 5
Ahmedabad 4
Amsterdam 4
Aracaju 4
Atlanta 4
Bucharest 4
Chicago 4
Düsseldorf 4
Gent 4
Groslay 4
Hong Kong 4
Medellín 4
Nanchang 4
Napoli 4
New Delhi 4
Orio Canavese 4
Phoenix 4
Prague 4
Redmond 4
Sanayi 4
Santiago 4
Upper Marlboro 4
West Jordan 4
Ambli 3
Totale 3.747
Salva come PNG Salva come JPEG
Nome #
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 641
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 364
Progranulin expression in brain tissue and cerebrospinal fluidlevels in multiple sclerosis 348
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 307
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. 265
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 206
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 132
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 102
Neurological comorbidity and severity of COVID-19 98
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 95
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 87
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 86
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI study. 83
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 82
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 81
Advanced therapies in Parkinson's disease: Long-term retrospective study 79
CIDP-like neuropathies in graft versus host disease 75
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 72
Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences 72
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 72
Transdermal rotigotine in dihydropteridine reductase deficiency 71
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 71
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 70
Neurodegeneration and iron accumulation in deep grey matter nuclei in multiple sclerosis. 68
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 68
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 68
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 68
Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease 68
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 63
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment 63
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 63
Autonomic dysfunction in Parkinson's disease: A prospective cohort study 62
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 61
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 61
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 61
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 58
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 58
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data 57
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 57
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 56
COVID-19 and Parkinson's Disease: What We Know So Far? 56
Parkinsonism–hyperpyrexia syndrome and deep brain stimulation 56
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study 54
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 52
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 52
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 51
A new index to assess turning quality and postural stability in patients with Parkinson's disease 50
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 49
Home monitoring of motor fluctuations in Parkinson’s disease patients 48
Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis 48
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit 48
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 48
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 47
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 47
COVID-19 in Parkinson's disease: Report on prevalence and outcome 45
Onset of Covid-19 with impaired consciousness and ataxia: a case report 44
Prevalence and burden of dysautonomia in advanced Parkinson's disease 43
Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study 43
Peripheral neuropathy as marker of severe Parkinson's disease phenotype 42
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease 42
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 42
Preliminary evidence from a Line-Bisection Task for visuospatial neglect in Parkinson's disease 41
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 41
Telemedicine in Neurological Disorders: Opportunities and Challenges 40
Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis 40
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure? 39
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 38
Neurological comorbidities and COVID-19-related case fatality: A cohort study 38
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 38
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 37
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 36
Functional neurological disorders in Parkinson disease 36
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 36
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 35
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 34
Levodopa-Induced Neuropathy: A Systematic Review 32
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 30
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 25
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants 24
Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease 22
Reply to: "Autonomic dysfunction in Parkinson's disease: The hidden game changer?" 21
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 18
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 17
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 12
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 5
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 4
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 2
Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease 2
Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations 1
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 1
Totale 6.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.094
article - articoli 0
book - libri 0
conference - conferenze 367
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.461
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019200 0 0 0 0 0 0 0 0 0 60 83 57
2019/2020808 33 16 36 81 71 83 98 77 80 90 66 77
2020/2021820 61 121 82 47 66 55 47 59 66 65 54 97
2021/20221.056 56 35 47 111 61 49 51 50 47 85 262 202
2022/20231.590 166 173 51 173 154 391 90 89 164 35 70 34
2023/2024613 111 129 42 28 76 96 26 46 4 55 0 0
Totale 6.371